Pediatrix Medical Group (FRA:PDC) FFO


FRA:PDC Pediatrix Medical Group Inc FRA:PDC
63 GF Score
Price €20.40
GF Value €11.23
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Pediatrix Medical Group FFO?

FFO (Funds from operations) only applies to REITs.

FRA:PDC
63GF Score
Pediatrix Medical Group Inc FRA:PDC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?

Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued. The current stock price of €20.40 is trading 81.7% above its estimated GF Value™ of €11.23. GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.

Key valuation signals for FRA:PDC:

  • FFO:
  • GF Value™: €11.23 vs. price of €20.40 (81.7% above fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pediatrix Medical Group Business Description

Other Exchanges MD:USA
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
63GF Score

Get the complete analysis for FRA:PDC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.40
Price
€11.23
GF Value